Cactus Acquisition 1 Limited priced its IPO of 11 million units, which begin trading today on the Nasdaq under CCTSU. Each consists of one Class A ordinary share and one-half of a warrant.
Once the securities begin separate trading, shares and warrants are expected to list under CCTS and CCTSW.
The SPAC intends to focus on Israel-related technology-based healthcare companies.
Oppenheimer and Moelis are joint book-running managers of the offering. The underwriters may opt to purchase up to an additional 1.65 million units to cover over-allotments, if any. Read more.
